Dr. Hasan Hashem

For physician enquiries and visit arrangements, call the KHCC central number, (number on ClinicsJo after signing in). Confirm the physician appointment, case acceptance and required documents before attending. (sign in to ClinicsJo to view the number)

When calling King Hussein Cancer Center, request extension 1073. Confirm the physician appointment and receiving location before attending.

Director of Pediatric Bone Marrow and Stem Cell Transplantation Pediatrics at King Hussein Cancer Center.

• M.B./B.S. University of Jordan, Jordan
• 2013-2016 Fellow, Pediatric Hematology/Oncology, Rainbow Babies & Children's Hospital, Case Western Reserve University, USA
• 2016-2017 Fellow, Pediatric Stem Cell Transplantation (BMT), Nationwide Children's Hospital, Ohio State University, USA
• Pediatrics Resident, University of Iowa Hospitals and Clinics, USA

• American Board of Pediatrics, 2013
• American Board of Pediatric Hematology/Oncology, 2017
• American Board of Pediatric Stem cell Transplantation, 2017
• Jordanian Board of pediatric Hematology/Oncology, 2018

• Resident: University of Iowa Hospitals and Clinics, Iowa, USA (2010-2013)
• Fellow: Rainbow Babies and Children's Hospital at case Western Reserve University, Cleveland, Ohio, USA (2013-2016)
• Fellow: Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA (2016-2017)
• Received $15,000 from The Marc Joseph Cancer Disocvery Fund in 2015 to study novel immunotherapy approaches to cure high risk sarcomas
• Received $5,500 in 2016 through a fellowship research award in pediatrics to study and define the role of expanded human NK cells in Ewing sarcoma

• ASPHO
• ASH
• ASBMT
• EBMT

• 2012: Certificate of awesomeness as super senior teacher, University Of Iowa
• 2013: The Gil Cuthbertson Award in overall excellence, University Of Iowa
• 2013: Gail McGuinness Award in the highest In-training exam score, University Of Iowa
• 2015: The Young Investigator Award for The Third Annual PBMTC at ASPHO conference

• Sultan I, Ajlouni F, Al-Jumaily U, Al-Ashhab M, Hashem H , Ghandour K, Masarweh M, Al-Hussaini M. Distinct Features of Teratoid Wilms Tumor. J Pediatr Surg . 2010 PMID: 20920703.
• Abu-Arja R, Hashem H , El-Sheikh A, Abusin G. Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis. Pediatric Blood Cancer . 2014 Review. PMID: 24376049.
• El-Sheikh AA, Hashem H, Holman C, Vyas YM. Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension with pigeon chest deformity. Pediatric Blood Cancer . 2014 PMID: 24420417.
• Hashem H , Lazarus H. Double Umbilical Cord Blood Transplantation: Relevance of Persistent Mixed-Unit Chimerism. Biol Blood Marrow Transplant . 2015 PMID: 25230381.
• Ding H, Hashem H , Cabral L, Rangarajan H, Abusin G, Lazarus H, Abu-Arja R. Azacitidine as a Bridge to Allogeneic Hematopoietic Cell Transplantation in a Pediatric Patient with Fanconi Anemia and Acute Myeloid Leukemia. Pediatric Transplantation . 2017 PMID: 27976488.
• Hashem H , Egler R, Dalal J. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2. J of Pediatr Hematol Oncol . 2017 PMID: 28230570.
• Bahar M, Hashem H , Tekautz T, Worley S, Tang A, de Blank P, Wolff J. Choroid Plexus Tumors in Adult and Pediatric Populations: The Cleveland Clinic and University Hospitals Experience. J Neurooncol . 2017 PMID: 28290001.
• Hashem H , Tong A, Eid S, Allen F, Kinsley D, and Huang AY. Adoptive Natural Killer Cell Therapy Is Effective In Reducing Pulmonary Metastasis of Ewing Sarcoma. OncoImmunology . 2017 PMID: 28507811.
• Vatsayan A, Hashem H , Kord H, Egler R, Norris R. Unusual Presentations of Chemotherapy Induced Acral Erythema after High Dose Methotrexate: Case Series. Clinical Research and Trials . 2017
• Gupta A, Pingfu F, Hashem H , Vatsayan A, Shein S, Dalal J. Outcomes and Healthcare Utilization in Children and Young Adults with Aplastic Anemia. A Multiinstitutional Analysis. Pediatric Blood Cancer . 2017 PMID: 28696061 .
• Hashem H , Vatsayan A, Gupta A, Nagle K, Hershfield M, Dalal J. Successful Reduced Intensity Hematopoietic Cell Transplant in a Patient with Deficiency of Adenosine Deaminase 2. Bone Marrow Transplant . 2017 PMID: 28805790.
• Hashem H , Kumar AR, Mueller I, Babor F, Brendius R, Dalal J, Hsu AP, Holland SM, Hickstein DD, Jolles S, Krance R, Sasa A, Taskinen M, Koskenvuo M, Saarela J, Van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Myets I. Hematopoietic Cell Transplantation Rescues the Hematological, Immunological and Vascular Phenotype in DADA2. Blood . 2017 PMID: 28974505. With Editorial .
• Hashem H , Kelly S, Ganson N, Hershfield MS. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders. Curr Rheumatol Rep . 2017 PMID: 28983775.
• Hashem H , Abu-Arja R, Auletta J, Rangarajan H, Varga E, Rose M, Bajwa R. Successful Second Hematopoietic Cell Transplant in Severe Congenital Neutropenia. Pediatric Transplantation . 2018 PMID: 29076228.
• Raina R, Abusin GA, Vijayaraghavan P, Auletta JJ, Cabral L, Vogt BA, Hashem H , Cooke KR, Abu-Arja RF. The Role of Continuous Renal Replacement Therapy in the Management of Acute Kidney Injury Associated with Sinusoidal Obstruction Syndrome Following Hematopoietic Cell Transplantation. Pediatric Transplantation . 2018 PMID: 29388370.
• Vatsayan A, Hashem H , Nagle K, Cabral L, Lazarus H, Dalal J. Combined Haploidentical and Umbilical Cord Blood Transplantation for Severe Aplastic Anemia: Unique Hematopoietic Reconstitution. Hematol Oncol Stem Cell Ther . 2018 PMID: 30176244.
• Lund TC, Ahn KW, Tecca HR, Hashem H , Hilgers MV, et al. Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. Biol Blood Marrow Transplant . 2019 PMID: 30244103
• Gonzales A, Gates E, Bhunia N, Mehyar L, Hashem H, Stanek J, Krebs B, Auletta J. Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic HCT. Biol Blood Marrow Transplant. 2019 PMID: 31085304
• Hashem H , Abu-Arja R, and Finlay J. Marrow-ablative Chemotherapy with Autologous Hematopoietic Cell Rescue in Brain Tumors. Newton/Handbook Book Chapter of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, 2 nd Edition . 2018

• Associate Member